Ligand Pharmaceuticals Incorporated Asset Turnover Ratio (LGND), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Ligand Pharmaceuticals Incorporated  (NASDAQ: LGND)
 

Ligand Pharmaceuticals Incorporated Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Due to the increase in investments during the second quarter 2026, Ligand Pharmaceuticals Incorporated's asset turnover ratio sequentially decreased to 0.17 in the second quarter (Jun 30 2026), this is lower than usual.

Within sector 116 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2026 compared to the preceding quarter from 2463 to 2562.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

LGND Asset Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Asset Change 129.58 % 68.77 % 65.31 % 54.64 % 9.58 %
Y / Y Revenue Change 33.73 % 14.09 % 40.01 % 122.85 % 14.68 %
Asset Turnover Ratio (TTM) 0.17 0.2 0.22 0.23 0.2
LGND's Total Ranking # 2562 # 2463 # 2531 # 2620 # 2606
Seq. Asset Change 42.67 % -1.83 % 5.48 % 55.39 % 4.88 %
Seq. Revenue Change 23.14 % -13.31 % -48.32 % 142.43 % 5.06 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 117
Healthcare Sector # 384
Overall Market # 2562

Asset Turnover Ratio Statistics
High Average Low
16.27 6.65 3.26
(Mar 31 2014)   (Jun 30 2020)




LGND Company Profile • Back to LGND Efficiency Comparisons • Compare LGND Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Gossamer Bio Inc   0.36 $ 53.286  Millions$ 146.709  Millions
Ionis Pharmaceuticals Inc   0.36 $ 1,169.419  Millions$ 3,238.360  Millions
Bionexus Gene Lab Corp   0.36 $ 3.127  Millions$ 8.660  Millions
Sensus Healthcare Inc   0.36 $ 18.294  Millions$ 51.035  Millions
Innovative Eyewear Inc   0.36 $ 3.412  Millions$ 9.567  Millions
Teva Pharmaceutical Industries Limited  0.35 $ 14,105.000  Millions$ 40,125.250  Millions
Cardiff Lexington Corporation  0.35 $ 10.213  Millions$ 29.417  Millions
Invo Fertility Inc   0.34 $ 7.531  Millions$ 22.386  Millions
Pelthos Therapeutics Inc   0.32 $ 43.304  Millions$ 134.891  Millions
Volitionrx Limited  0.32 $ 2.458  Millions$ 7.672  Millions
Opko Health Inc   0.31 $ 587.896  Millions$ 1,903.425  Millions
Pfizer Inc  0.31 $ 63,696.000  Millions$ 206,410.000  Millions
Sonida Senior Living Inc   0.31 $ 525.973  Millions$ 1,718.907  Millions
Orchestra Biomed Holdings Inc   0.29 $ 31.976  Millions$ 109.006  Millions
Utah Medical Products Inc  0.29 $ 35.679  Millions$ 123.368  Millions
Immunitybio inc   0.29 $ 165.792  Millions$ 574.007  Millions
Amarin Corp Plcuk  0.29 $ 186.480  Millions$ 650.179  Millions
Orasure Technologies Inc  0.29 $ 111.978  Millions$ 391.497  Millions
Maravai Lifesciences Holdings Inc   0.28 $ 207.886  Millions$ 734.183  Millions
Atara Biotherapeutics Inc   0.28 $ 6.452  Millions$ 22.856  Millions
Assembly Biosciences Inc   0.28 $ 74.845  Millions$ 265.982  Millions
Fortress Biotech Inc   0.27 $ 69.983  Millions$ 260.136  Millions
Adc Therapeutics Sa  0.27 $ 79.584  Millions$ 295.946  Millions
Repligen Corp  0.27 $ 785.101  Millions$ 2,938.591  Millions
Invivyd Inc   0.27 $ 58.365  Millions$ 219.167  Millions
Humacyte Inc   0.26 $ 30.074  Millions$ 114.130  Millions
Hcw Biologics Inc   0.26 $ 6.843  Millions$ 26.019  Millions
Bio rad Laboratories Inc   0.26 $ 2,589.000  Millions$ 10,078.725  Millions
Plus Therapeutics Inc   0.24 $ 4.203  Millions$ 17.235  Millions
Elutia Inc   0.24 $ 11.353  Millions$ 47.654  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.